B cell biology: implications for treatment of systemic lupus erythematosus.
about
Proteasome inhibitors in progressive renal diseasesTreatment of Bullous Systemic Lupus ErythematosusGenetics of systemic lupus erythematosus: immune responses and end organ resistance to damage.The pathogenesis, diagnosis and treatment of lupus nephritis.Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signalingActivation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus.Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.Reflections on Lupus 2013: butterflies, wolves and prophecies.Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.Effect of Leflunomide on the Abnormal Expression of Lipid Rafts and F-Actin in B Lymphocytes from Patients with Systemic Lupus ErythematosusIncreased Serum Interleukin-9 Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Pathogenic Role or Just an Epiphenomenon?IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism.Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.Targeting B cells and autoantibodies in the therapy of autoimmune diseases.Rituximab and lupus--a promising pair?All- Trans-Retinoic Acid Augments the Histopathological Outcome of Neuroinflammation and Neurodegeneration in Lupus-Prone MRL/lpr Mice.B cells biology in systemic lupus erythematosus-from bench to bedside.Lupus nephritis and B-cell targeting therapy.Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1.B cell contribution of the CD4+ T cell inflammatory phenotypes in systemic lupus erythematosus.Inhibition of G Protein βγ Subunit Signaling Abrogates Nephritis in Lupus-Prone Mice.The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotypeMeasuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus.Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease.Increase of MZB1 in B cells in systemic lupus erythematosus: proteomic analysis of biopsied lymph nodes.PKK deficiency in B cells prevents lupus development in Sle lupus mice.Targeting the B-cell pathway in lupus nephritis: current evidence and future perspectives.Relative Contributions of B Cells and Dendritic Cells from Lupus-Prone Mice to CD4+ T Cell Polarization.B Cell-Related Circulating MicroRNAs With the Potential Value of Biomarkers in the Differential Diagnosis, and Distinguishment Between the Disease Activity and Lupus Nephritis for Systemic Lupus Erythematosus.
P2860
Q27011485-B85208BD-0415-4A85-9C30-665395E05457Q28087628-1FCDE2CA-3811-4367-99DD-F2AA455DFB10Q30301191-E2A9F092-318B-4686-A67A-0CADD80D41B8Q30596968-379C7BE7-1DAF-4AF9-9366-9B93548A92D1Q33421410-52AAB00D-3152-4E18-A240-9B5B4AFD4A6DQ33691812-21719A84-EA9E-4D72-A699-A5BAB21DBDDDQ34476578-232CC799-EAB8-40F0-A6D9-DA50D16261D6Q34587471-6B8D6962-FEFC-4015-9765-6AC8611ADC5DQ34976836-A0A14276-CE41-44DC-A576-A9533D1649BBQ35182476-2A268ADB-60DA-4E07-9A39-FCF3960A3688Q35674006-2000F301-FAC6-4C34-8910-738F3B81132CQ35674703-35F60705-9DD0-472A-9723-6137B968BEECQ36923706-D6541BF2-4A19-439E-9517-8F1BA05FEF3EQ37730801-B4FE14B7-D9DC-4EF2-8C29-4F77E5786F0BQ38207937-79E8CF95-7843-4891-B01F-27621B3DBDBFQ38235185-2A10E652-174A-4F94-90DD-55B7CD0D83AFQ38406678-B07B6885-F5BA-4B41-9820-5807C1C620DEQ38631964-EA691BE7-DCF6-4639-8368-57975EB214EBQ38643755-17AB8EF9-A444-4326-9AEB-84761711D091Q38877460-9A925CFB-5127-4363-B072-5A07A02274FDQ39122679-2ED1E3DC-4AA8-498C-B64B-9E4C0D9EE757Q39909362-DD93E4FD-9C7F-411F-A4FC-7F3482B6D028Q40695129-9CD2CDE0-1FF2-45C7-96C8-59FA5E380E19Q41532554-DF842826-303B-4D23-A97A-14568229A79AQ42220485-970F2E91-1E7D-47B6-B647-180A2D70D0CAQ47548339-AA83A7CC-E1D1-4E09-A6EC-EE5F152369CCQ49192001-8BBE913E-63DF-4BDD-8C62-F9B3E64AE814Q50678340-AC24D491-23F5-4A39-8543-8CDA00C627ADQ51345238-632EEA8A-5585-475F-ACB6-A8E20D909119Q54251519-3EC7F9A3-3465-4162-8381-0BB164C7139AQ55658051-665187FF-29B4-43A8-A578-A65736995916
P2860
B cell biology: implications for treatment of systemic lupus erythematosus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
B cell biology: implications for treatment of systemic lupus erythematosus.
@en
type
label
B cell biology: implications for treatment of systemic lupus erythematosus.
@en
prefLabel
B cell biology: implications for treatment of systemic lupus erythematosus.
@en
P2860
P356
P1433
P1476
B cell biology: implications for treatment of systemic lupus erythematosus.
@en
P2093
J H Anolik
P2860
P304
P356
10.1177/0961203312471576
P577
2013-04-01T00:00:00Z